These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31270835)
21. Association between Breslow thickness and dermoscopic findings in acral melanoma. Mun JH; Jo G; Darmawan CC; Park J; Bae JM; Jin H; Kim WI; Kim HS; Ko HC; Kim BS; Kim MB J Am Acad Dermatol; 2018 Nov; 79(5):831-835. PubMed ID: 29906546 [TBL] [Abstract][Full Text] [Related]
22. Reproducibility of AJCC staging parameters in primary cutaneous melanoma: an analysis of 4,924 cases. Niebling MG; Haydu LE; Karim RZ; Thompson JF; Scolyer RA Ann Surg Oncol; 2013 Nov; 20(12):3969-75. PubMed ID: 23851608 [TBL] [Abstract][Full Text] [Related]
23. A retrospective comparison between preoperative and postoperative Breslow depth in primary cutaneous melanoma: how preoperative shave biopsies affect surgical management. Saco M; Thigpen J J Drugs Dermatol; 2014 May; 13(5):531-6. PubMed ID: 24809875 [TBL] [Abstract][Full Text] [Related]
24. Non-invasive analysis of melanoma thickness by means of dermoscopy: a retrospective study. Stante M; De Giorgi V; Cappugi P; Giannotti B; Carli P Melanoma Res; 2001 Apr; 11(2):147-52. PubMed ID: 11333124 [TBL] [Abstract][Full Text] [Related]
25. Sentinel node biopsy status is strongly predictive of survival in cutaneous melanoma: Extended follow-up of Oxford patients from 1998 to 2014. Thomson DR; Rughani MG; Kuo R; Cassell OCS J Plast Reconstr Aesthet Surg; 2017 Oct; 70(10):1397-1403. PubMed ID: 28625757 [TBL] [Abstract][Full Text] [Related]
26. [Metastatic melanoma of low Breslow thickness]. Hundeiker M; Lippold A; Peters A Hautarzt; 1997 Mar; 48(3):171-4. PubMed ID: 9182087 [TBL] [Abstract][Full Text] [Related]
27. Characteristics of 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research Database. Jimenez Balcells C; Hay J; Keir J; Rosendahl N; Coetzer-Botha M; Wilson T; Clark S; Baade A; Becker C; Bookallil L; Clifopoulos C; Dicker T; Denby MP; Duthie D; Elliott C; Fishburn P; Foley M; Franck M; Giam I; Gordillo P; Lilleyman A; Macauley R; Maher J; McPhee E; Reid M; Shirlaw B; Siggs G; Spark R; Stretch J; van den Heever K; van Rensburg T; Watson C; Kittler H; Rosendahl C Australas J Dermatol; 2021 Nov; 62(4):496-503. PubMed ID: 34423846 [TBL] [Abstract][Full Text] [Related]
28. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma. Hofmann MA; Gussmann F; Fritsche A; Biesold S; Schicke B; Küchler I; Voit C; Trefzer U Melanoma Res; 2009 Feb; 19(1):17-23. PubMed ID: 19104451 [TBL] [Abstract][Full Text] [Related]
30. Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study. Swetter SM; Soon S; Harrington CR; Chen SC Arch Dermatol; 2007 Jan; 143(1):30-6. PubMed ID: 17224539 [TBL] [Abstract][Full Text] [Related]
31. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma. Uliasz A; Lebwohl M Int J Dermatol; 2007 Jun; 46(6):575-7. PubMed ID: 17550554 [TBL] [Abstract][Full Text] [Related]
32. Distance to diagnosing provider as a measure of access for patients with melanoma. Stitzenberg KB; Thomas NE; Dalton K; Brier SE; Ollila DW; Berwick M; Mattingly D; Millikan RC Arch Dermatol; 2007 Aug; 143(8):991-8. PubMed ID: 17709657 [TBL] [Abstract][Full Text] [Related]
33. Melanoma screening clinics: are we detecting more melanomas or reassuring the worried well? Weatherhead SC; Lawrence CM Br J Dermatol; 2006 Mar; 154(3):539-41. PubMed ID: 16445788 [TBL] [Abstract][Full Text] [Related]
34. Impact of skin cancer screening on melanoma thickness and stage. Morr C; Prechtel TJ; Hardacker R; Bell M; Slaven JE; Que SKT J Am Acad Dermatol; 2024 Jun; 90(6):1280-1282. PubMed ID: 38360176 [No Abstract] [Full Text] [Related]
35. Pathological review of primary cutaneous malignant melanoma by a specialist skin cancer multidisciplinary team improves patient care in the UK. Bhoyrul B; Brent G; Elliott F; McLorinan J; Wilson A; Peach H; Mathew B; Mitra A J Clin Pathol; 2019 Jul; 72(7):482-486. PubMed ID: 31088937 [TBL] [Abstract][Full Text] [Related]
36. Does palpability of primary cutaneous melanoma predict dermal invasion? O'Donnell BF; Marsden JR; O'Donnell CA; Sanders DS; Billingham C J Am Acad Dermatol; 1996 Apr; 34(4):632-7. PubMed ID: 8601653 [TBL] [Abstract][Full Text] [Related]
37. Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors. Lo SN; Scolyer RA; Thompson JF Ann Surg Oncol; 2018 Apr; 25(4):894-902. PubMed ID: 29330716 [TBL] [Abstract][Full Text] [Related]
38. Are cutaneous melanomas of specified thickness showing deeper levels of invasion at diagnosis? Luke CG; Coventry BJ; Foster-Smith EJ; Roder DM Asian Pac J Cancer Prev; 2003; 4(4):307-11. PubMed ID: 14728588 [TBL] [Abstract][Full Text] [Related]
39. Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma. Stiegel E; Xiong D; Ya J; Funchain P; Isakov R; Gastman B; Vij A J Am Acad Dermatol; 2018 May; 78(5):942-948. PubMed ID: 29408526 [TBL] [Abstract][Full Text] [Related]
40. Clinical correlates of Breslow thickness of malignant melanoma. Osborne JE; Hutchinson PE Br J Dermatol; 2001 Mar; 144(3):476-83. PubMed ID: 11260002 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]